Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Tetanus × Granulocyte-Macrophage Colony-Stimulating Factor × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neuroblastoma 11 Leukemia 9 Prostatic Neoplasms 8 Breast Neoplasms 7 Neoplasm Metastasis 6 Melanoma 6 Myelodysplastic Syndromes 5 Multiple Myeloma 5 Lymphoma, Non-Hodgkin 5 Lymphoma 5 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 5 Leukemia, Lymphocytic, Chronic, B-Cell 5 Glioblastoma 5 Carcinoma, Non-Small-Cell Lung 5 Ovarian Neoplasms 4 Lymphoma, Large B-Cell, Diffuse 4 Leukemia, Myeloid, Acute 4 Fallopian Tube Neoplasms 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Kidney Neoplasms 3 Glioma 3 Carcinoma, Renal Cell 3 Breast Neoplasms, Male 3 Osteosarcoma 2 Neoplasms 2 Lymphoma, Mantle-Cell 2 Lymphoma, Follicular 2 Lung Neoplasms 2 Hodgkin Disease 2 Colorectal Neoplasms 2

Interventions

sargramostim 1 Temozolomide 1 Granulocyte-Macrophage Colony-Stimulating Factor 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03927222 2024-04-08

I-ATTAC

Duke University

Phase 2 Terminated

6 enrolled 7 charts

Glioblastoma, Tetanus

Data powered by HemOnc (CC BY 4.0) Colophon ⚡